Hematology Specialist Association

Congress Presentations

The 3rd International Eurasian Hematology Congress Presentations has been issued.

III. INTERNATIONAL EURASIAN CONGRESS OF HEMATOLOGY PROGRAM
17-21 OCTOBER 2012

17 October 2012 Wednesday In memory of ATİLLA YALCIN -Special Session-
16:00-16:30	Opening Speech	Suleyman Dincer
Presidential Lectures	Giuseppe Saglio, Birol Guvenc
16.30-17.00	Current therapeutical options for acute myeloid leukemia	Alan Burnett
17.00-17.30	How will change stem cell transplantation in the future?	Richard Champlin
17.30-18.00	The impact of genomics in clinical medicine: Tracing tumor mutational evolution through single cell genomics	Vera Donnenberg
18.00	Opening Cocktail

18 October 2012 Thursday
Iron Overload
Moderators :İlhan Tezcan Yurdanur Kilinc, Nazli D. Kaya
09.00-9.30	Chelation therapy in 2012	Antonio Piga
9.30-10.00	Iron Overload in MDS	Elizer Rachmilewitz
10.00-10.30	Transplantation in thalassemia patients	Gulyuz Ozturk
10.30-10.45	Coffee Break
Myeloproliferative Disorders
Moderators : Ali Keskin, Hakan Ozdogu
10.45-11.15	The complex biology of myeloproliferative disorders	Selim Yavuz
11.15-11.45	Conventional therapy of MPDs: When SCT maybe indicated?	Selim Yavuz
11.45-12.15	Molecular targeted therapy of MPDs	Mustafa Cetiner
12.30-13.30	Lunch
Myelodysplastic Syndromes
Moderators : Ali Unal, Bulent Eser
13.30-14.00	Biological and clinical heterogeneity of MDS	Giuseppe Saglio
14.00-14.30	Current classification and risk scoring in MDS	Mehmet Ali Ozcan
14.30-15.00	Hypomethylation and hypomethylating agents in MDS	Aysen Timuragaoglu
15.00-15.15	Coffee Break
Acute Lymphoblastic Leukemia
Moderators : Atilla Tanyeli, Yuri Chervonobab
15.15-15.45	Adult ALL therapy in 2012	Dieter Hoeltzer
15.45-16.15	Pediatric ALL therapy in 2012	Bulent Antmen
Chronic Myeloid Leukemia
Moderators : Cengiz Beyan, Salih Aksu
16.15-16.45	Present approaches to CML therapy in 2012	Naeem Chaudhri
16.45-17.15	Monitoring response of CML patients	Guray Saydam
17.15-17.45	What have we learned from CML that are useful for other hematologic malignancies?	Giuseppe Saglio

19 October 2012 Friday
Chronic Lymphocytic Leukemia and Indolent Lymphomas
Moderators : Sehmuz Ertop, Hasan Kaya
09.00-9.30	Current diagnostic stratification of CLL patients	Costas Stamatopoulos
9.30-10.00	Current therapy approaches for CLL	Emili Montserrat
10.00-10.30	Present approaches for indolent lymphomas	Berksoy Sahin
10.30-10.45	Coffee Break
High Grade Lymphomas
Moderators : Ali Kosar, Osman Ilhan
10.45-11.15	Diagnosis and risk stratification of high grade lymphomas	Filiz Vural
11.15-12.30	Chemotherapy-antibodies stem cell transplantation? How can we better combine all these approaches for high-grade lymphomas?	Burhan Ferhanoglu
12.30-13.00	Hodgkin Lymphoma	Alessandro Levis
13.00-14.00	Lunch
Multiple Myeloma
Moderators : Rauf Haznedar, Orhan Ayyildiz
14.00-14.30	Conventional therapy of MM therapy in young and elderly patients	Ismet Aydogdu
14.30-15.00	When proteasome inhibitors in the therapy of MM?	Raphael Fonseca
15.00-15.30	Optimization of Bortezomib Treatment in Multiple Myeloma	Michel Delforge
15.30-15.45	Coffee Break
Stem Cell Transplantation
Moderators : Oktay Faradjov, Nikolai Tupitsyn, Vahap Okan
15.45-16.15	Therapeutic use of non hematopoietic stem cells	Albert Donnenberg
16.15-16.45	Fungal infections in the immune-compromised patients: Which prevention? Which therapy?	Sesin Kocagoz
16.45-17.15	Bacterial and viral infections in the immune-compromised patients: Which prevention? Which therapy?	Gokhan Metan

20 October 2012 Saturday
Practical Approaches in Apheresis and Transfusion
Moderators : Ercument Ovali, Nilgun Sayinalp
09.00-09.15	Country-based experiences in apheresis, transfusion, stem cell collection and processing	Ferda Tekinturhan
9.15-09:30	Transplantation in Kirghizstan	Abdulhalim Rahimjanov
09.30-09.45	Bening Hematology in Uzbekistan	Saidcalal Bahramov
09.45-10.00	Current therapeutic options for low-grade malignant lymphoma recurrences	Oktay Faradjov
10.00-10.30	How to setup a modern blood bank? Equipment, personnel and management	Turker Cetin
10.30-10.45	Coffee Break
Transplantation
Moderators : Suleyman Dincer, Deniz Sargin
10.45-11.15	When RIC should be preferred in SCT?	Richard Champlin
11.15-11.45	Haploidentical or cord blood stem cells; which and when?	Hakan Goker
11.45-12.15	Management of graft-versus host disease in 2012	Ahmet Ifram
12.30-13.30	Lunch
Special Topics-I
Moderators : Mustafa Solak, Oktay Faradjov, Bulent Zulfukar
13.30-14.00	The benefits of prophylaxis from early age till adulthood in persons with hemophilia	Jan Blanty
14.00-14.30	Diseases and diagnosis of paroxysmal nocturnal hemoglobinuria	Ozlem Balcik
14.30-15.00	Current treatment approaches for paroxysmal nocturnal hemoglobinuria – medical case	Fuat Oduncu
15.00-15.15	Coffee Break
Acute Myeloblastic Leukemia
Moderators : Ahmet Ozturk, Mehmet Turgut
15.15-15.45	Importance of genetic classification in the management of AML	Mustafa Yenerel
15.45-16.15	Best induction therapy in AML	Mehmet Yilmaz
16.15-16.45	Which AML patients should be transplanted?	Sevgi Kalayoglu Besisik
16.45-17.00	Coffee Break
Selected Topics-II
Moderators : Bulent Zulfukar, Birol Güvenc
17.00-17.30	Thrombotic microangiopathy: Current knowledge and outcomes with plasma exchange	Joseph Kiss
17.30-18.00	Atypical HUS	Sibel Kabukcu
18.00-18.30	Rational use of medicines	Birol Guvenc